home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Investment-in-Innovation (IN3) EAST

 
  December 10, 2012  
     
 
Elsevier Business Intelligence, Hyatt Regency Boston, MA
June 24-26, 2013


Join us in Boston this June and Gain Critical Perspective on the Challenges and Opportunities Facing All Players in the Evolving Global Medical Device Market


Elsevier Business Intelligence, publisher of the "The Gray Sheet," IN VIVO, START-UP and Medtech Insight, is pleased to announce Investment In Innovation (IN3) Medical Device 360° Boston 2013.

In today's increasingly complex, globally driven healthcare environment, your business requires up-to-the-minute market expertise on all the critical factors impacting your success. EBI, as a leader in the field of healthcare industry data and analysis, gives medical technology executives a full 360° view of their market, opportunities and challenges. The upcoming IN³ Medical Device 360° Boston 2013 conference, marking EBI's 13th year of successful and highly anticipated investment and partnering events, with IN³ events held in Boston each of these years, is a true reflection of this 360° spirit.

Building on the success of past IN³ events in Dublin, London, Paris, Rome, Brussels, and across the U.S., this must-attend event, being held in the epicenter of device innovation and investment on the East Coast, will bring together development- to commercial-stage device start-ups from around the world seeking funding or strategic partnership with top-tier venture capital and strategic decision makers. The two-day conference will also feature international industry experts examining the most pressing issues facing our global industry in 2013 and beyond, via a variety of financing, business development, clinical/regulatory, reimbursement, and emerging market panel discussions and presentations, and networking sessions.

 
 
Organized by: Elsevier Business Intelligence
Invited Speakers:

Who Attends?

  • Presidents, Principals, CEOs, CTOs, COOs, CMOs
  • Founders, Board Leaders, Chairpersons
  • Venture Partners, Senior Investors, Private Equity, Angel Investors
  • VPs/Directors of Strategic Planning, Business Development/Analysis, Marketing, New Technology, Acquisitions, R&D, Sales

From These Types of Companies

  • Established, large device companies seeking technology via licensing, partnering, and acquisition to broaden or deepen product lines or build sector strength.
  • VCs, private equity, investment firms/consultant, and investment banks.
  • Medical device, biopharmaceutical, biotech, or other company executives seeking investments or partnerships
 
Deadline for Abstracts: To be updated
 
Registration:

For detailed registration information, please contact:

Kristy J. Kennedy
Sales Director, Medical Device
Phone: 1-480-985-9512
Email: k.kennedy@elsevier.com

 

Kayleen Kell
Associate Account Manager
Phone: 1-949-797-7142
1-855-202-5939 toll-free in the USA
Email: k.kell@elsevier.com

E-mail: k.kennedy@elsevier.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.